JLK Inc (322510) - Total Liabilities

Latest as of June 2026: ₩34.80 Billion KRW ≈ $23.58 Million USD

Based on the latest financial reports, JLK Inc (322510) has total liabilities worth ₩34.80 Billion KRW (≈ $23.58 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check 322510 asset resilience ratio to evaluate the company's liquid asset resilience ratio.

JLK Inc - Total Liabilities Trend (2017–2025)

This chart illustrates how JLK Inc's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see JLK Inc (322510) total assets.

JLK Inc Competitors by Total Liabilities

The table below lists competitors of JLK Inc ranked by their total liabilities.

Company Country Total Liabilities
Prozone Realty Limited
NSE:PROZONER
India Rs7.01 Billion
South Basic Chemicals JSC
VN:CSV
Vietnam ₫519.44 Billion
La Kaffa International Co Ltd
TWO:2732
Taiwan NT$3.68 Billion
Kyongbo Pharmaceutical Co Ltd
KO:214390
Korea ₩220.58 Billion
Kyungdong City Gas Co Ltd
KO:267290
Korea ₩453.62 Billion
Intech Biopharm Ltd
TWO:6461
Taiwan NT$1.34 Billion
Toma as
PR:TOMA
Czech Republic Kč964.46 Million
FitLife Brands, Inc. Common Stock
NASDAQ:FTLF
USA $55.22 Million

Liability Composition Analysis (2017–2025)

This chart breaks down JLK Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See JLK Inc (322510) balance sheet quality index to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 1.85 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 1.00 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.50 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how JLK Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for JLK Inc (2017–2025)

The table below shows the annual total liabilities of JLK Inc from 2017 to 2025.

Year Total Liabilities Change
2025-12-31 ₩33.07 Billion
≈ $22.41 Million
+30.82%
2024-12-31 ₩25.28 Billion
≈ $17.13 Million
+17.95%
2023-12-31 ₩21.43 Billion
≈ $14.52 Million
+8.71%
2022-12-31 ₩19.71 Billion
≈ $13.36 Million
+20.46%
2021-12-31 ₩16.36 Billion
≈ $11.09 Million
+3.02%
2020-12-31 ₩15.88 Billion
≈ $10.76 Million
+562.49%
2019-12-31 ₩2.40 Billion
≈ $1.62 Million
-27.95%
2018-12-31 ₩3.33 Billion
≈ $2.26 Million
-76.05%
2017-12-31 ₩13.90 Billion
≈ $9.42 Million
--

About JLK Inc

KQ:322510 Korea Conglomerates
Market Cap
$87.63 Million
₩129.31 Billion KRW
Market Cap Rank
#19774 Global
#1030 in Korea
Share Price
₩5060.00
Change (1 day)
+1.91%
52-Week Range
₩3815.00 - ₩9000.00
All Time High
₩29001.77
About

JLK, Inc. provides diagnosis support to the patients with its AI-driven medical platform in South Korea. The company offers AI medical and AI security solutions. Its AI platform provides on-site/real-time service that is connected to various systems built in the hospital and enables the professional needs of physicians to diagnose diseases. The company provides medical management, medical treatme… Read more